Evidence map›Paper›PMID 37289288›Full record

ArticleMetabolomics : Official journal of the Metabolomic Society2023

Mitochondrial damage-induced abnormal glucose metabolism with ageing in the hippocampus of APP/PS1 mice.

Shijie Li, Yangyang Wang, Xiong Zhang, Xiaomin Xiong, Fanlin Zhou, Xiaoju Li, Jianing Fan, Xiao Liang, Guangxin Li, Yan Peng and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolomics : Official journal of the Metabolomic Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. PINK1 deficiency permits the development of Lewy body dementia with coexisting Aβ pathology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Shijie LiChongqing University Cancer Hospital, Chongqing, 400030, P.R. China.
Yangyang WangSchool of Medicine, Chongqing University, Chongqing, 400030, P.R. China.
Xiong ZhangBasic Medicine College, Chongqing Medical University, Chongqing, P.R. China.
Xiaomin XiongSchool of Medicine, Chongqing University, Chongqing, 400030, P.R. China.
Fanlin ZhouChongqing University Cancer Hospital, Chongqing, 400030, P.R. China.
Xiaoju LiChongqing University Cancer Hospital, Chongqing, 400030, P.R. China.
Jianing FanSchool of Medicine, Chongqing University, Chongqing, 400030, P.R. China.
Xiao LiangSchool of Medicine, Chongqing University, Chongqing, 400030, P.R. China.
Guangxin LiChongqing University Cancer Hospital, Chongqing, 400030, P.R. China.
Yan PengTeaching and Research Section of Pathology and Pathophysiology, School of Basic Medical Science, Chongqing Medical University, Chongqing, 400016, P.R. China.
Yu LiChongqing University Cancer Hospital, Chongqing, 400030, P.R. China. liyu100@cqu.edu.cn.
Chongqing University · CNChongqing Cancer Hospital · CNChongqing Medical University · CN

Funding

The Fundamental Research Funds for the Central University No. 2019CDYGZD002The Performance Incentive Guidance for Scientific Research Institution of Chongqing No. cstc2020jxjl130013
6 · The paper itself

Abstract

introductionAccumulation of β-amyloid (Aβ) in neurons of patients with Alzheimer's disease (AD) inhibits the activity of key enzymes in mitochondrial metabolic pathways, triggering mitochondrial dysfunction, which plays an important role in the onset and development of AD. Mitophagy is a process whereby dysfunctional or damaged mitochondria are removed from the cell. Aberrant mitochondrial metabolism may hinder mitophagy, promote autophagosome accumulation, and lead to neuronal death.

objectivesThe aim of this experiment is to explore the mechanism of neuronal mitochondria damage in the hippocampus of different age APP/PS1 double transgenic AD mice, and to explore the related metabolites and metabolic pathways for further understanding of the pathogenesis, so as to provide new ideas and strategies for the treatment of AD.

methodsIn this study, 24 APP/PS1(APPswe/PSEN1dE9) mice were divided into 3, 6, 9, and 12-month-old groups, and 6-month-old wild-type C57BL/6 mice were as controls. The Morris water maze test was used to evaluate learning and memory. Levels of Aβ were detected by immunohistochemistry. Electron microscopy was used to observe mitochondrial damage and autophagosome accumulation. Western blot was for measuring LC3, P62, PINK1, Parkin, Miro1, and Tom 20 protein expression levels. Gas chromatography coupled with mass spectrometry was used to screen differentially abundant metabolites.

resultsThe results showed that with the increase of age in APP/PS1 mice, cognitive impairment, hippocampal neuron mitochondrial damage, and autophagosome accumulation all increased. Furthermore, enhanced mitophagy and impaired mitochondrial clearance leading to metabolic abnormalities were observed with ageing in APP/PS1 mouse hippocampus. Especially, abnormal accumulation of succinic acid and citric acid in the Krebs cycle was observed.

conclusionThis study investigated the abnormal glucose metabolism associated with age-related damage to mitochondria in the hippocampus of APP/PS1 mice. These findings provide new insights into the pathogenesis of AD.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAgingAnimalsGas Chromatography-Mass SpectrometryGlucoseHippocampusMetabolomicsMiceMice, Inbred C57BLMice, TransgenicAmyloid beta-Protein PrecursorGlucoseAlzheimer’s disease (AD)Glucose metabolism; AgeHippocampusMitochondrial autophagy

Identifiers

PMID37289288
OpenAlexW4379768063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.